MRC1 and cancer: Furthermore, the specific binding motif we developed could be incorporated to provide highly specific targeted delivery of therapeutic drugs to enable repolarization of CD206+ macrophages (e.g., in cancer and fibrosis) as therapeutic or theranostic agents.